Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

UM-164

Catalog No. T4597Cas No. 903564-48-7
Alias UM164, DAS-DFGO-II

UM-164 (DAS-DFGO-II), a highly potent c-Src inhibitor with a dissociation constant (Kd) of 2.7 nM, also effectively inhibits p38α and p38β.

UM-164

UM-164

Purity: 99.52%
Catalog No. T4597Alias UM164, DAS-DFGO-IICas No. 903564-48-7
UM-164 (DAS-DFGO-II), a highly potent c-Src inhibitor with a dissociation constant (Kd) of 2.7 nM, also effectively inhibits p38α and p38β.
Pack SizePriceAvailabilityQuantity
1 mg$30In Stock
2 mg$43In Stock
5 mg$68In Stock
10 mg$122In Stock
25 mg$198In Stock
50 mg$297In Stock
100 mg$439In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "UM-164"

Select Batch
Purity:99.52%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
UM-164 (DAS-DFGO-II), a highly potent c-Src inhibitor with a dissociation constant (Kd) of 2.7 nM, also effectively inhibits p38α and p38β.
Targets&IC50
c-Src:2.7 nM
In vitro
UM-164 is an effective inhibitor of c-Src, showing a binding potency close to that of Dasatinib (UM-164 Kd=2.7 nM, Dasatinib Kd=0.7 nM) in biochemical assays. Its capability to inhibit c-Src activation was assessed through its effect on c-Src autophosphorylation in MDA-MB 231 and SUM 149 TNBC cell lines, revealing concentration- and time-dependent inhibition. Notably, at 120 minutes and a concentration of 50 nM, UM-164 completely abrogated c-Src autophosphorylation, confirming its potent inhibitory action in vitro. Additionally, flow cytometry experiments indicated that UM-164 treatment increased the proportion of G0-G1 cells by 25% and 28% in MDA-MB 231 and SUM 149 cells respectively, while simultaneously decreasing the S cell fraction by 16% and 19%, respectively[1].
In vivo
In a xenograft study, NCr/nude mice implanted with MDA-MB 231 and SUM 149 cell lines are observed. Once tumors are palpable, mice are divided into control and treatment groups, receiving intraperitoneal injections of either the drug (doses of 10 and 20 mg/kg for both cell types, with an additional 15 mg/kg for SUM 149) or a vehicle bi-daily (n=5 per group). Following treatment with UM-164 at selected doses, no noteworthy adverse effects like weight loss or abnormalities are evident in treated mice even after 52 days. Importantly, tumor growth is significantly reduced in both 10 and 20 mg/kg dosage groups compared to the vehicle group (P<0.026 and P<0.004, respectively)[1], demonstrating the compound's efficacy.
Cell Research
MDA-MB 231 and SUM 149 cells are plated in triplicate on 60 mm dishes at a density of 1×106 cells/flask. After 24 h, a final concentration of 1 μM UM-164 is added to the cells and incubated for 24 h. Growth medium is then removed and cells are washed with PBS. The remaining cells are trypsinized, harvested, and placed together with growth medium and PBS. Cells are pelleted and re-suspended in 3 mL of 75% ethanol, followed by overnight storage at - 20°C. After incubation, cells are centrifuged at 1,500 rpm for 5 min and the cell pellets are re-suspended in 0.05 mg/mL propidium iodide (10 μg/mL) containing 300 μg/mL RNase. Cell clumps are filtered. Cell DNA content is measured on flow cytometer and cell cycle distribution is calculated from 10,000 cells using FACS analysis[1] .
Animal Research
Mice[1]
AliasUM164, DAS-DFGO-II
Chemical Properties
Molecular Weight640.68
FormulaC30H31F3N8O3S
Cas No.903564-48-7
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 6.41 mg/mL (10 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.5608 mL7.8042 mL15.6084 mL78.0421 mL
5 mM0.3122 mL1.5608 mL3.1217 mL15.6084 mL
10 mM0.1561 mL0.7804 mL1.5608 mL7.8042 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy UM-164 | purchase UM-164 | UM-164 cost | order UM-164 | UM-164 chemical structure | UM-164 in vivo | UM-164 in vitro | UM-164 formula | UM-164 molecular weight